Extension Study of Protocol DFA102 to Examine the Long-Term Safety, Tolerability, and Effect on Body Weight of Pramlintide Administered in Combination With Metreleptin
Clinical trial NCT00819234 · COMPLETED
Trial details
- NCT number
- NCT00819234
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2009-10-01
- Enrollment
- 274
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.